2,784 vaccinations later

April 29, 2011 By Jonathan Wood
Mothers and babies taking part in the trial in South Africa.

The two thousand, seven hundred and eighty-fourth baby has been vaccinated today in South Africa as part of a clinical trial of a new vaccine against tuberculosis. The new TB vaccine is the most advanced in development anywhere in the world.

That’s the last baby in the trial, and marks completion of trial enrolment almost two years to the day after the study was first announced.

"We are extremely proud of this achievement and are eager to see the study results, which are expected to be available in 2012," says Dr. Helen McShane, who developed the at the Jenner Institute, Oxford University. "This milestone brings us a step closer to potentially having a new , from which millions of people around the world would benefit."

It’s certainly quite a milestone, and marks a great deal of work to vaccinate all these babies under 1 year old in an area where there is one of the highest rates of TB in the world.

But why precisely 2,784 babies, not 2,500 or 3,000?

Helen explains that it is entirely down to the calculations used to plan the trial. These sums showed that 2784 babies should give enough statistical weight to be able to see a significant improvement in preventing TB over the 90-year-old (but still standard) BCG jab.

The new vaccine is designed to be given to infants after they have received the BCG vaccine, boosting the immune response further. All the babies in the trial have received the BCG vaccine, with half then getting the trial vaccine and half a placebo. "If successful, the next steps would be to plan a phase III trial and licensure of the vaccine," Helen says.

The current trial was a phase IIb trial, and is the first to be able to really determine whether the vaccine gives infants any protection against TB. A larger phase III trial would pin down exactly the size of any benefit and guide how the vaccine could be rolled out.

The trial in Worcester, about 100km from Cape Town, is being conducted by the University of Cape Town’s South African Vaccine Initiative (SATVI), in partnership with Aeras, the Wellcome Trust, and the Oxford-Emergent Tuberculosis Consortium Ltd (a joint venture between the University of Oxford and Emergent Biosolutions Inc formed to develop the vaccine)

"We are pleased to report that the trial has run smoothly to date," says Dr. Hassan Mahomed, who has led the trial at SATVI.

Explore further: Trials begin for 'essential' new TB vaccine

Related Stories

Trials begin for 'essential' new TB vaccine

July 30, 2007

Clinical trials are underway with the first new vaccine against TB in over 80 years. If successful, the tests will have major implications for TB control and could lead to the development of a new vaccine ready to use within ...

TB vaccine enters new clinical trials

April 23, 2009

(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate vaccine for more ...

New TB booster shows promise

March 16, 2010

A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.

New TB vaccine enters clinical testing

September 23, 2010

At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be ...

Tuberculosis vaccine passes phase I trial

March 24, 2011

(PhysOrg.com) -- The currently available tuberculosis vaccine BCG is over 90 years old – and its effectiveness is declining. An increasing number of mycobacterial strains are emerging, against which the current vaccine ...

Recommended for you

Treatment options for opioid addiction are expanding

August 10, 2016

In the past two decades, the devastation associated with opioid addiction has escaped the relative confines of the inner city and extended to suburban and rural America. Due in large part to the proliferation of prescription ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.